Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769806 · ClinicalTrials.gov registry record
Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 16
- Enrollment target
NCT02769806: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT02769806 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02769806 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The primary aim of this project is to Compare new msCS and standard DSC-PWI methods in GBM patients undergoing post-operative MRI for monitoring of tumor progression.
Primary Outcome
A novel high resolution DSC-PWI method will be compared to the standard DSC-PWI method to determine whether novel method improves image quality in tumor regions.
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-05-23 |
| Est. Completion | 2019-06-21 |
Why NCT02769806 stopped before completion
NCT02769806 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02769806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02769806 about?
NCT02769806 is a clinical study titled "Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma". The primary aim of this project is to Compare new msCS and standard DSC-PWI methods in GBM patients undergoing post-operative MRI for monitoring of tumor progression.
What is the current status of trial NCT02769806?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2016-05-23. Estimated completion is 2019-06-21.
What interventions are being tested in trial NCT02769806?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02769806?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI